104
Views
3
CrossRef citations to date
0
Altmetric
Eco/Toxicology

Preliminary evaluation of Prodigiosa herbal tea: cytotoxicity and GLUT2 expression in HepG2 cells

&
Pages 669-678 | Received 28 Jan 2013, Accepted 27 Apr 2013, Published online: 03 Jun 2013

References

  • Akakura, N., M. Kobayashi, I. Horiuchi, A. Suzuki, J. Wang, J. Chen, H. Niizeki, Ki Kawamura, M. Hosokawa, and M. Asaka. 2001. “Constitutive Expression of Hypoxia-Inducible Factor-1 Alpha Renders Pancreatic Cancer Cells Resistant to Apoptosis Induced by Hypoxia and Nutrient Deprivation.” Cancer Research 61 (17): 6548–6554.
  • Ashrafian, H. 2006. “Cancer's Sweet Tooth: The Janus Effect of Glucose Metabolism in Tumorigenesis.” Lancet 367 (9510): 618–621.
  • Barbosa Filho, J.M.T.H.C. Vasconcelos, A.A. Alencar, L.M. Batista, R.A.G. Oliveira, D.N. Guedes, H.S. Falcao, M.D. Moura, M.F.F.M. Diniz, and J. Modesto-Filho. 2005. “Plants and Their Active Constituents from South, Central and North America With Hypoglycemic Activity.” Brazilian Journal of Pharmacognosy 15 (4): 392–413.
  • Berridge, M.V., A.S. Tan, K.D. McCoy, M. Kansara, and F. Rudert. 1996. “CD95 (Fas/Apo-1)-Induced Apoptosis Results in Loss of Glucose Transporter Function.” Journal of Immunology 156 (11): 4092–4099.
  • Borradaile, N.M., L.E. de Dreu, and M.W. Huff. 2003. “Inhibition of Net Hepg2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation.” Diabetes 52 (10): 2554–2561.
  • Borradaile, N.M., L.E. de Dreu, P.H. Barrett, C.D. Behrsin, and M.W. Huff. 2003. “Hepatocyte apoB-Containing Lipoprotein Secretion is Decreased by the Grapefruit Flavonoid, Naringenin, via Inhibition of MTP-Mediated Microsomal Triglyceride Accumulation.”Biochemistry 42 (5): 1283–1291.
  • Calabrese, E.J. 2005. “Historical Blunders: How Toxicology got the Dose-Response Relationship Half Right.” Cellular and Molecular Biology (Noisy-le-Grand, France) 51 (7): 643–654.
  • Calabrese, E.J., M.E. McCarthy, and E. Kenyon. 1987. “The Occurrence of Chemically Induced Hormesis.” Health Physics 52 (5): 531–541.
  • Calabrese, E.J., and R.R. Cook. 2005. “Hormesis: How it Could Affect the Risk Assessment Process.” Human and Experimental Toxicology 24 (5): 265–270.
  • Carayannopoulos, M.O., M.M. Chi, Y. Cui, J.M. Pingsterhaus, R.A. McKnight, M. Mueckler, S.U. Devaskar, and K.H. Moley. 2000. “GLUT8 is a Glucose Transporter Responsible for Insulin-Stimulated Glucose Uptake in the Blastocyst.” Proceeding of the National Academy of Sciences of the United States of America 97 (13): 7313–7318.
  • Chen, C., N. Pore, A. Behrooz, F. Ismail-Beigi, and A. Maity. 2001. “Regulation of GLUT1 mRNA by Hypoxia-Inducible Factor-1. Interaction Between H-ras and Hypoxia.” Journal of Biological Chemistry 276 (12): 9519–9525.
  • Ducluzeau, P.H., L.M. Fletcher, H. Vidal, M. Laville, and J.M. Tavare. 2002. “Molecular Mechanisms of Insulin-Stimulated Glucose Uptake in Adipocytes.” Diabetes and Metabolism 28 (2): 85–92.
  • Eisenberg, M.L., A.V. Maker, L.A. Slezak, J.D. Nathan, K.C. Sritharan, B.P. Jena, J.P. Geibel, and D.K. Andersen. 2005. “Insulin Receptor (IR) and Glucose Transporter 2 (GLUT2) Proteins Form a Complex on the Rat Hepatocyte Membrane.” Cellular Physiology and Biochemistry 15 (1–4): 51–58.
  • Fu, P.P., Q. Xia, G. Lin, and M.W. Chou. 2004. “Pyrrolizidine Alkaloids –Genotoxicity, Metabolism Enzymes, Metabolic Activation, and Mechanisms.” Drug Metabolism Reviews 36 (1): 1–55.
  • Grobholz, R., H.J. Hacker, B. Thorens, and P. Bannasch. 1993. “Reduction in the Expression of Glucose Transporter Protein GLUT2 in Preneoplastic and Neoplastic Hepatic Lesions and Reexpression of GLUT 1 in Late Stages of Hepatocarcinogenesis.” Cancer Research 53 (18): 4204–4211.
  • Hacker, H.J., B. Thorens, and R. Grobholz. 1991. “Expression of Facilitative Glucose Transporter in Rat-Liver and Choroid-Plexus — A Histochemical Study in Native Cryostat Sections.” Histochemistry 96 (5): 435–439.
  • Heinrich, M., M. Robles, J.E. West, B.R. Ortiz de Montellano, and E. Rodriguez. 1998. “Ethnopharmacology of Mexican Asteraceae (Compositae).” Annual Reviews of Pharmacology and Toxicology 38: 539–565.
  • Hernandez-Galicia, E., A. Aguilar-Contreras, L. Aguilar-Santamaria, R. Roman-Ramos, A.A. Chavez-Miranda, L.M. Garcia-Vega, J.L. Flores-Saenz, and F.J. Alarcon-Aguilar. 2002. “Studies on Hypoglycemic Activity of Mexican Medicinal Plants.” Proceedings of the Western Pharmacology Society 45: 118–124.
  • Huang, R.F., Y.H. Ho, H.L. Lin, J.S. Wei, and T.Z. Liu. 1999. “Folate Deficiency Induces a Cell Cycle-Specific Apoptosis in HepG2 Cells.” Journal of Nutrition 129 (1): 25–31.
  • Khan, A.H., E. Capilla, J.C. Hou, R.T. Watson, J.R. Smith, and J.E. Pessin. 2004. “Entry of Newly Synthesized GLUT4 into the Insulin-Responsive Storage Compartment is Dependent Upon Both the Amino Terminus and the Large Cytoplasmic Loop.” Journal of Biological Chemistry 279 (36): 37505–37511.
  • Khan, M.A., M.C. Gannon, and F.Q. Nuttall. 1992. “Glucose Appearance Rate Following Protein Ingestion in Normal Subjects.” Journal of the American College of Nutrition 11 (6): 701–706.
  • Liu, A.J., N. Hou, and L.Z. Chen. 2001. “Expression of Glucose Transporter-1 in Endometrial Hyperplasia and Well-Differentiated Endometrioid Adenocarcinoma”. Acta Academiae Medicinae Sinicae (Zhongguo Yi Xue Ke Xue Yuan Xue Bao) 23 (4): 398–400.
  • Moley, K.H., M.M. Chi, and M.M. Mueckler. 1998. “Maternal Hyperglycemia Alters Glucose Transport and Utilization in Mouse Preimplantation Embryos.” American Journal of Physiology 275 (1 Pt 1): E38–E47.
  • Moore, M. 1989. Medicinal Plants of the Desert and Canyon West: A Guide to Identifying, Preparing, and Using Traditional Medicinal Plants Found in the Deserts and Canyons of the West and Southwest.” Sante Fe, New Mexico: Museum of New Mexico Press.
  • Nascarella, M.A., and E.J. Calabrese. 2009. “The Relationship Between the IC(50), Toxic Threshold, and the Magnitude of Stimulatory Response in Biphasic (Hormetic) Dose-Responses.” Regulatory Toxicology and Pharmacology 54 (3): 229–233.
  • Neuman, M.G., G. Koren, and C. Tiribelli. 1993. “In vitro Assessment of the Ethanol-Induced Hepatotoxicity on HepG2 Cell Line.” Biochemical and Biophysical Research Communications 197 (2): 932–941.
  • Perez-Gutierrez, R.M., C. Perez-Gonzalez, M.A. Zavala-Sanchez, and S. Perez-Gutierrez. 1998. “Hypoglycemic Activity of Bouvardia Terniflora, Brickellia Veronicaefolia, and Parmentiera Edulis.” Salud Publica De Mexico 40 (4): 354–358.
  • Pham, T.T., T. Oyama, T. Isse, and T. Kawamoto. 2009. “Application of Tryptophan Fluorescence to Assess Sensitizing Potentials of Chemicals.” Archives of Environmental Contamination and Toxicology 57 (3): 427–436.
  • Popat, A., N.H. Shear, I. Malkiewicz, M.J. Stewart, V. Steenkamp, S. Thomson, and M.G. Neuman. 2001. “The Toxicity of Callilepis Laureola, a South African Traditional Herbal Medicine.” Clinical Biochemistry 34 (3): 229–236.
  • Poss, J.E., M.A. Jezewski, and A.G. Stuart. 2003. “Home Remedies for Type 2 Diabetes Used by Mexican Americans in El Paso, Texas.” Clinical Nursing Research 12 (4): 304–323.
  • Ramachandran, B.R., A.B. Gentles, S.B. Cox, and E.E. Smith. 2006. “Age-Dependent Characterization of Pendrin Gene Expression in Various Tissues of Deer Mice.” Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology 145 (3–4): 338–345.
  • Seevaratnam, R., B.P. Patel, and M.J. Hamadeh. 2009. “Comparison of Total Protein Concentration in Skeletal Muscle as Measured by the Bradford and Lowry Assays.” Journal of Biochemistry 145 (6): 791–797.
  • Tobin, V., M. Le Gall, X. Fioramonti, E. Stolarczyk, A.G. Blazquez, C. Klein, M. Prigent, et al. 2008. “Insulin Internalizes GLUT2 in the Enterocytes of Healthy but not Insulin-Resistant Mice.” Diabetes 57 (3): 555–562.
  • Velasco, L.R., J.C. Perez, R.T. Aguilar, R. Roman Ramos, L.V. Carrillo, and F. Alarcon Aguilar. 2005. “Detection of Cytotoxic Activity of Psacalium Palladium on Normal Mouse Spleen Cells and Transformed Human Cells.” Proceedings of the Western Pharmacology Society 48: 150–153.
  • Winer, J., C.K. Jung, I. Shackel, and P.M. Williams. 1999. “Development and Validation of Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction for Monitoring Gene Expression in Cardiac Myocytes in vitro.” Analytical Biochemistry 270 (1): 41–49.
  • Xue, T.H., and R. Roy. 2003. “Studying Traditional Chinese Medicine.” Science 300 (5620): 740–741.
  • Zhu, J.Q., R. Vinas, and E.E. Smith. 2008. “In vitro Evaluation of Human Liver Cancer Cells and the Potential Cytotoxicity of Tecoma Stans (Bignoniaceae) and Brickellia Cavanillesi (Asteraceae) Both Single and in Combination.” Toxicological and Environmental Chemistry 90 (4): 801–808.
  • Zick, S.M., A. Blume, and K.D. Aaronson. 2005. “The Prevalence and Pattern of Complementary and Alternative Supplement Use in Individuals With Chronic Heart Failure.” Journal of Cardiac Failure 11 (8): 586–589.
  • Zisman, A., O.D. Peroni, E.D. Abel, M.D. Michael, F. Mauvais-Jarvis, B.B. Lowell, J.F. Wojtaszewski, et al. 2000. “Targeted Disruption of the Glucose Transporter 4 Selectively in Muscle Causes Insulin Resistance and Glucose Intolerance.” Nature Medicine 6 (8): 924–928.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.